6ix — Find Your Next Investment

Discover investor relations events, company profiles, and investment opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
19m ago	Pacific Valley Bancorp Shows Continued Growth in Loans and Deposits and Improved Profitability in the First Quarter of 2026
20m ago	U-BX Technology Ltd. Announces Pricing of $4.55 Million Registered Direct Offering
20m ago	Company’s 3-for-1 Stock Split Cleared by FINRA for OTC Markets Trading
20m ago	L.B. Foster Company to Report First Quarter 2026 Results on May 4, 2026
21m ago	Peripheral T-Cell Lymphoma Market to Witness Significant Expansion at a CAGR of 7% During the Forecast Period (2026–2036) Amid Advancing Treatment Landscape \| DelveInsight

About

Marker Therapeutics Inc (NASDAQ:MRKR) — investor relations, events, news, and company updates on 6ix.

Latest News

Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results

Marker Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

Good Morning America Features Baylor College of Medicine Pancreatic Cancer Study Utilizing Marker Therapeutics’ MAR-T Cell Technology

Baylor College of Medicine Publishes Promising Safety and Efficacy Results of Multi-Antigen Targeted T Cells in Patients with Pancreatic Cancer

Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates

Financials

Revenue

$3.55 M

Market Cap

$18.24 M

EPS

-0.79

Community Chat

Ask AI